Clinical Trial Update: IMPROVE Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial updating the IMPROVE intervention using non-invasive circulating tumor DNA to guide operative and postoperative treatment in colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Karen-Lise Garm Spindler | Conditions: Colorectal Cancer, Circulating Tumor DNA | Phase 2 | Status: UNKNOWN